Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Industry Report Lists Anti-Infection Drugs in Pipeline

MRSA bacteria (CDC)

Scanning electron micrograph image of MRSA bacteria (Janice Haney Carr, Centers for Disease Control and Prevention)

The Pharmaceutical Research and Manufacturers of America (PhRMA) released today a report listing 395 new drugs designed to fight infections that are nearing the marketplace. Each of the drugs are either in clinical trials or under review by the U.S. Food and Drug Administration.

More than one-third of the drugs on the PhRMA list — 145 of 395 — are vaccines designed to prevent or treat diseases such as staph infections and pneumococcal infections. Another 96 drugs, about a quarter of those listed, are antivirals to treat viruses as hepatitis, herpes and influenza. The list does not include, however, 97 other drugs to treat HIV/AIDS that are in testing. Some 88 drugs listed are antibiotics or antibacterials for treating bacterial infections such as pneumonia and tuberculosis.

PhRMA says 18 of the new medicines or vaccines treat or prevent staph infections and sepsis. More than 94,000 people contracted Methicillin-Resistant Staphylococcus aureus (MRSA) infections in 2005, with nearly 19,000 dying from MRSA during hospital stays, according to the U.S. Centers for Disease Control and Prevention. Sepsis, a life-threatening illness, can occur when staph bacteria spread to the bloodstream. Sepsis has nearly doubled in the last 10 years, and is expected to kill 215,000 people in the U.S. this year.

Some of the drugs listed are designed to treat illnesses in the developing world. For example, six medicines and five vaccines for malaria are currently in development.

Related: Drug Companies Urged to Conserve Antibiotics to Fight Resistance

1 comment to Industry Report Lists Anti-Infection Drugs in Pipeline

  • Hello,

    I recently read your article about MRSA and I wanted to bring to your attention to my product PureGreen24 Disinfectant.

    PureGreen24’s Advantages:

    PureGreen24 kills Swine Flu H1N1, MRSA, Staph and the most deadly of superbugs, yet also kills everyday household germs. PureGreen24’s advantages include: fastest bacterial/ viral/ fungal kill times, 24 hour residual protection against Staph, Salmonella and E. Coli. EPA registered for use on sports equipment and children’s toys (no rinsing required for skin contact). PureGreen24 disinfects without bleaching and is odorless with no harsh chemical smell. PureGreen24 does not require Warning labeling unlike all other disinfectants. PureGreen24 contains NO toxic chemicals.

    PureGreen24 is registered by the EPA to disinfect surfaces that may be contaminated with MRSA and Staph.

    PureGreen24’s 24 hour residual protection can help stop the spread of this dangerous bacteria, MRSA can live for hours if not days on surfaces. A proper disinfection routine can make the difference of spreading this very contagious Bactria to others.

    Visit http://www.PureGreen24.com for further details.